(−)-Epigallocatechin-3-gallate (EGCG) ameliorates ovalbumin-induced asthma by inhibiting inflammation via the TNF-α/TNF-R1/NLRP3 signaling pathway

Beibei Zhang(Yunnan University), Weisheng Feng(First Affiliated Hospital of Henan University), Yuanyuan Wu(First Affiliated Hospital of Henan University), Mengnan Zeng(Henan Bioengineering Technology Research Center), Qi-Mei Tie(First Affiliated Hospital of Henan University), Ru Wang(Fuzhou University), Mengya Wang(First Affiliated Hospital of Henan University)
International Immunopharmacology
December 3, 2024
Cited by 17


Related Papers